Is Ruxolitinib an Effective and Safe Therapy for Chronic Myeloproliferative Diseases?Burcu Aslan Candır,Sema Seçilmiş,Ersin Bozan,Samet Yaman,Tuğçe Nur Yiğenoğlu,Merih Kızıl Çakar,Mehmet Sinan Dal,Fevzi Altuntaş,Fevzi AltuntasActa Oncologica Turcica(2024)引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要